leftspacer middlespacer rightspacer
Media Menu
Featured Material

MAPS Bulletin Winter 2013: 2013 Annual Report
Media > Recent and Archival
December 6, 2013

Boulder: Fourth Subject Enrolled and Treated; Fifth Subject Enrolled

On December 6, 2013, the fourth subject began treatment in our ongoing Boulder, Colorado, study of MDMA-assisted psychotherapy for 17 subjects with chronic, treatment-resistant PTSD. This subject was enrolled on November 18, and the fifth subject was enrolled on November 20. Two subjects have now completed their one-month follow-up evaluations. Goals for this study include (1) gathering evidence for the safety and effectiveness of MDMA-assisted psychotherapy for subjects with PTSD from a variety of causes, (2) comparing different doses of MDMA for therapeutic effectiveness and ability to create a successful double-blind, (3) exploring whether using intern co-therapists can reduce costs while maintaining treatment effectiveness, and (4) training the next generation of psychedelic psychotherapists.

Back to MAPS in the Media

Give Our Veterans Hope
1 in 7 Iraq and Afghanistan veterans suffer from PTSD, in many cases leading to suicide. We owe it to our veterans to stop this epidemic.

Tell the Pentagon to fund MAPS' groundbreaking work to treat PTSD.